New User? Sign Up | Sign In

Insider Trading - UBS Oncology Impact Fund L.P.

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Email a friend >>...

SPAC List: List of Special Purpose Acquisition Companies

Insider Trading Transactions for UBS Oncology Impact Fund L.P.

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2017-11-02
Purchase
2017-11-06
9:27 pm
SUNESIS PHARMACEUTICALS INC SNSS MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
UBS Oncology Impact Fund L.P.
10% Owner
81,500 $2.773 $226,001 3,331,500
(Indirect)
View
2019-02-12
Purchase
2019-02-14
5:34 pm
Harpoon Therapeutics Inc. HARP UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
10% Owner
250,000 $14 $3,500,000 3,898,422
(Direct)
View
2019-02-12
Sale
2019-02-14
5:34 pm
Harpoon Therapeutics Inc. HARP UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
10% Owner
447 $14 $6,258 3,898,422
(Direct)
View
2019-02-19
Purchase
2019-02-21
6:06 pm
TCR2 THERAPEUTICS Inc TCRR UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
10% Owner
666,667 $15 $10,000,005 3,370,982
(Direct)
View
2020-07-28
Purchase
2020-07-30
08:00 am
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
320,000 $19 $6,080,000 2,355,557
(Indirect)
View
2020-10-06
Purchase
2020-10-08
6:26 pm
Oncorus Inc. ONCR UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
10% Owner
151,224 $15 $2,268,360 2,377,025
(Direct)
View
2021-01-12
Purchase
2021-01-14
5:54 pm
Cullinan Management Inc. CGEM UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
10% Owner
300,000 $21 $6,300,000 7,913,887
(Direct)
View
2021-04-07
Sale
2021-04-09
4:47 pm
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
10% Owner
41,982 $30.99 $1,300,850 6,004,568
(Indirect)
View
2021-04-09
Sale
2021-04-13
4:13 pm
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
30,928 $21.9 $677,357 7,105,800
(Indirect)
View
2021-04-09
Sale
2021-04-13
4:15 pm
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
10% Owner
200 $29.99 $5,998 6,004,368
(Indirect)
View
2021-04-13
Sale
2021-04-15
8:00 pm
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
38,556 $20.16 $777,359 7,067,244
(Indirect)
View
2021-04-16
Sale
2021-04-20
6:07 pm
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
38,152 $19.04 $726,550 7,029,092
(Indirect)
View
2021-04-21
Sale
2021-04-22
4:04 pm
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
8,972 $18.97 $170,229 7,020,120
(Indirect)
View
2021-04-27
Sale
2021-04-29
5:46 pm
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
130,143 $21.99 $2,861,368 6,889,977
(Indirect)
View
2021-04-30
Sale
2021-05-04
5:43 pm
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
328,519 $22.48 $7,386,435 6,561,458
(Indirect)
View
2021-05-05
Sale
2021-05-06
4:05 pm
Harpoon Therapeutics Inc. HARP GADICKE ANSBERT
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
UBS Oncology Impact Fund L.P.
10% Owner
10,172 $22.52 $229,107 6,551,286
(Indirect)
View
2021-05-04
Purchase
2021-05-06
4:19 pm
Werewolf Therapeutics Inc. HOWL GADICKE ANSBERT
MPM ONCOLOGY INNOVATIONS FUND LP
UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Innovations Fund GP LLC
MPM Oncology Impact Management GP LLC
10% Owner
245,000 $16 $3,920,000 6,672,183
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2019-02-12
Conversion
2019-02-14
5:34 pm
N/A
N/A
Harpoon Therapeutics Inc. HARP UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
10% Owner
1,525,165 $0 1,525,165
(Direct)
View
2019-02-12
Conversion
2019-02-14
5:34 pm
N/A
N/A
Harpoon Therapeutics Inc. HARP UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
10% Owner
1,578,755 $0 3,103,920
(Direct)
View
2019-02-12
Conversion
2019-02-14
5:34 pm
N/A
N/A
Harpoon Therapeutics Inc. HARP UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
10% Owner
417,853 $0 3,521,773
(Direct)
View
2019-02-12
Exercise
2019-02-14
5:34 pm
N/A
N/A
Harpoon Therapeutics Inc. HARP UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
10% Owner
127,096 $0.0492 3,648,869
(Direct)
View
2019-02-12
Conversion
2019-02-14
5:34 pm
N/A
N/A
Harpoon Therapeutics Inc. HARP UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
10% Owner
1,525,165 $0 0
(Direct)
View
2019-02-12
Conversion
2019-02-14
5:34 pm
N/A
N/A
Harpoon Therapeutics Inc. HARP UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
10% Owner
1,578,755 $0 0
(Direct)
View
2019-02-12
Conversion
2019-02-14
5:34 pm
N/A
N/A
Harpoon Therapeutics Inc. HARP UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
10% Owner
417,853 $0 0
(Direct)
View
2019-02-12
Exercise
2019-02-14
5:34 pm
2016-11-01
2026-11-01
Harpoon Therapeutics Inc. HARP UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
10% Owner
76,258 $0 0
(Direct)
View
2019-02-12
Exercise
2019-02-14
5:34 pm
2017-01-10
2027-01-10
Harpoon Therapeutics Inc. HARP UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
10% Owner
50,838 $0 0
(Direct)
View
2019-02-19
Conversion
2019-02-21
6:06 pm
N/A
N/A
TCR2 THERAPEUTICS Inc TCRR UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
10% Owner
2,421,775 $0 2,421,775
(Direct)
View
2019-02-19
Conversion
2019-02-21
6:06 pm
N/A
N/A
TCR2 THERAPEUTICS Inc TCRR UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
10% Owner
282,540 $0 2,704,315
(Direct)
View
2019-02-19
Conversion
2019-02-21
6:06 pm
N/A
N/A
TCR2 THERAPEUTICS Inc TCRR UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
10% Owner
15,000,000 $0 0
(Direct)
View
2019-02-19
Conversion
2019-02-21
6:06 pm
N/A
N/A
TCR2 THERAPEUTICS Inc TCRR UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Impact Management GP LLC
10% Owner
1,750,000 $0 0
(Direct)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
1,269,230 $0 1,269,230
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
84,655 $0 84,655
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
43,687 $0 43,687
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
801,619 $0 801,619
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
42,605 $0 42,605
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
15,820 $0 15,820
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
1,397,574 $0 1,397,574
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
724,702 $0 1,993,932
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
48,336 $0 132,991
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
24,944 $0 68,381
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
457,706 $0 1,259,325
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
24,326 $0 66,931
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
9,033 $0 24,853
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
797,983 $0 2,195,557
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
3,824,591 $0 0
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
255,094 $0 0
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
131,645 $0 0
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
2,415,530 $0 0
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
128,384 $0 0
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
47,674 $0 0
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
4,211,330 $0 0
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
2,361,805 $0 0
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
157,529 $0 0
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
81,295 $0 0
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
1,491,666 $0 0
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
79,281 $0 0
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
29,440 $0 0
(Indirect)
View
2020-07-28
Conversion
2020-07-30
08:00 am
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
Director
10% Owner
2,600,628 $0 0
(Indirect)
View
2020-10-06
Conversion
2020-10-08
6:26 pm
N/A
N/A
Oncorus Inc. ONCR UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
10% Owner
1,525,348 $0 1,525,348
(Direct)
View
2020-10-06
Conversion
2020-10-08
6:26 pm
N/A
N/A
Oncorus Inc. ONCR UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
10% Owner
700,453 $0 2,225,801
(Direct)
View
2020-10-06
Conversion
2020-10-08
6:26 pm
N/A
N/A
Oncorus Inc. ONCR UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
10% Owner
1,525,348 $0 0
(Direct)
View
2020-10-06
Conversion
2020-10-08
6:26 pm
N/A
N/A
Oncorus Inc. ONCR UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
10% Owner
700,453 $0 0
(Direct)
View
2021-01-12
Conversion
2021-01-14
5:54 pm
N/A
N/A
Cullinan Management Inc. CGEM UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
10% Owner
1,136,525 $0 1,136,525
(Direct)
View
2021-01-12
Conversion
2021-01-14
5:54 pm
N/A
N/A
Cullinan Management Inc. CGEM UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
10% Owner
3,551,640 $0 4,688,165
(Direct)
View
2021-01-12
Conversion
2021-01-14
5:54 pm
N/A
N/A
Cullinan Management Inc. CGEM UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
10% Owner
2,276,692 $0 6,964,857
(Direct)
View
2021-01-12
Conversion
2021-01-14
5:54 pm
N/A
N/A
Cullinan Management Inc. CGEM UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
10% Owner
649,030 $0 7,613,887
(Direct)
View
2021-01-12
Conversion
2021-01-14
5:54 pm
N/A
N/A
Cullinan Management Inc. CGEM UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
10% Owner
1,136,525 $0 0
(Direct)
View
2021-01-12
Conversion
2021-01-14
5:54 pm
N/A
N/A
Cullinan Management Inc. CGEM UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
10% Owner
3,551,640 $0 0
(Direct)
View
2021-01-12
Conversion
2021-01-14
5:54 pm
N/A
N/A
Cullinan Management Inc. CGEM UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
10% Owner
2,276,692 $0 0
(Direct)
View
2021-01-12
Conversion
2021-01-14
5:54 pm
N/A
N/A
Cullinan Management Inc. CGEM UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
MPM Oncology Impact Management LP
10% Owner
649,030 $0 0
(Direct)
View
2021-04-07
Other
2021-04-09
4:47 pm
N/A
N/A
iTeos Therapeutics Inc. ITOS GADICKE ANSBERT
UBS Oncology Impact Fund L.P.
MPM Oncology Impact Management LP
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management GP LLC
10% Owner
15,670 $0 6,036,872
(Indirect)
View
2021-05-04
Conversion
2021-05-06
4:19 pm
N/A
N/A
Werewolf Therapeutics Inc. HOWL GADICKE ANSBERT
MPM ONCOLOGY INNOVATIONS FUND LP
UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Innovations Fund GP LLC
MPM Oncology Impact Management GP LLC
10% Owner
4,477,742 $0 4,939,150
(Indirect)
View
2021-05-04
Conversion
2021-05-06
4:19 pm
N/A
N/A
Werewolf Therapeutics Inc. HOWL GADICKE ANSBERT
MPM ONCOLOGY INNOVATIONS FUND LP
UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Innovations Fund GP LLC
MPM Oncology Impact Management GP LLC
10% Owner
1,488,033 $0 6,427,183
(Indirect)
View
2021-05-04
Conversion
2021-05-06
4:19 pm
N/A
N/A
Werewolf Therapeutics Inc. HOWL GADICKE ANSBERT
MPM ONCOLOGY INNOVATIONS FUND LP
UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Innovations Fund GP LLC
MPM Oncology Impact Management GP LLC
10% Owner
38,818,000 $0 0
(Indirect)
View
2021-05-04
Conversion
2021-05-06
4:19 pm
N/A
N/A
Werewolf Therapeutics Inc. HOWL GADICKE ANSBERT
MPM ONCOLOGY INNOVATIONS FUND LP
UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
MPM Oncology Impact Management LP
MPM Oncology Innovations Fund GP LLC
MPM Oncology Impact Management GP LLC
10% Owner
12,899,925 $0 0
(Indirect)
View